Huffington Post: Who can get a coronavirus test?
UC expert says screenings will have to be reserved for higher-risk patients
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by the Huffington Post for a story on who can get tested for coronavirus.
Dr. Carl Fichtenbaum in a lab in the UC Division of Infectious Diseases. Photo credit/Joe Fuqua II/UC Creative + Brand
Dr. Fichtenbaum said until the availability of testing increases, screenings will have to be reserved for higher-risk patients.
Fichtenbaum said that if you have mild symptoms of the virus, the advice is going to be the same whether you have a positive test: “Stay home untll you’re better. Quarantine yourself away from family or roommates or friends. Get rest plenty of liquids. Take some cough syrup or Tylenol for aches and pains.”
Read the full article here.
Dr. Fichtenbaum was also featured in a separate Huffington Post article on how coronavirus tests work. Read that article here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.